Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Bloom

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cell Reports. Medicine|April 21, 2026
Plasma extracellular vesicle proteomics nominates candidate biomarkers of <sup>177</sup>Lu-PSMA-617 outcomes in metastatic prostate cancer patientsAli T Arafa, Ella Boytim, Megan L Ludwig, et al.
The British Journal of Radiology|January 24, 2025
Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trialMaira Hameed, Stuart A Taylor, Norin Ahmed, et al.
Insights Into Imaging|March 19, 2025
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's diseaseNaomi S Sakai, Andrew A Plumb, Norin Ahmed, et al.
Health Technology Assessment (Winchester, England)|August 22, 2019
Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy studyStuart A Taylor, Sue Mallett, Gauraang Bhatnagar, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2018
Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trialStuart A Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
European Radiology|May 14, 2025
Magnetic resonance enterography to predict subsequent disabling Crohn's disease in newly diagnosed patients (METRIC-EF)-multivariable prediction model, multicentre diagnostic inception cohortStuart A Taylor, Shankar Kumar, Thomas Parry, et al.
Journal of Crohn'S & Colitis|December 28, 2018
Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort StudyMark A Samaan, Katrina Forsyth, Jonathan P Segal, et al.
Frontline Gastroenterology|May 19, 2020
Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UKRukshana Kapasi, Jackie Glatter, Christopher A Lamb, et al.
Gut|April 19, 2020
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemicNicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cell Reports. Medicine|April 21, 2026
Plasma extracellular vesicle proteomics nominates candidate biomarkers of <sup>177</sup>Lu-PSMA-617 outcomes in metastatic prostate cancer patientsAli T Arafa, Ella Boytim, Megan L Ludwig, et al.
The British Journal of Radiology|January 24, 2025
Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trialMaira Hameed, Stuart A Taylor, Norin Ahmed, et al.
Insights Into Imaging|March 19, 2025
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's diseaseNaomi S Sakai, Andrew A Plumb, Norin Ahmed, et al.
Health Technology Assessment (Winchester, England)|August 22, 2019
Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy studyStuart A Taylor, Sue Mallett, Gauraang Bhatnagar, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2018
Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trialStuart A Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
European Radiology|May 14, 2025
Magnetic resonance enterography to predict subsequent disabling Crohn's disease in newly diagnosed patients (METRIC-EF)-multivariable prediction model, multicentre diagnostic inception cohortStuart A Taylor, Shankar Kumar, Thomas Parry, et al.
Journal of Crohn'S & Colitis|December 28, 2018
Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort StudyMark A Samaan, Katrina Forsyth, Jonathan P Segal, et al.
Frontline Gastroenterology|May 19, 2020
Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UKRukshana Kapasi, Jackie Glatter, Christopher A Lamb, et al.
Gut|April 19, 2020
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemicNicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, et al.
Pageof 5